Influenza A(H3N2) Changes in Europe: 2023/24 Season Insights
Author Information
Author(s): Eeva K Broberg, Maja Vukovikj, Olov Svartström, Iris Hasibra, Maximilian Riess, Angeliki Melidou
Primary Institution: European Centre for Disease Prevention and Control (ECDC)
Hypothesis
How do the circulating influenza viruses in the EU/EEA during the 2023/24 season compare to the vaccine components?
Conclusion
The 2023/24 influenza season showed co-circulation of various influenza types, with significant genetic diversification observed in A(H3N2) viruses.
Supporting Evidence
- 154,718 influenza virus detections were reported during the study period.
- 97% of detections were type A viruses.
- 23% of A(H3N2) viruses were antigenically distinct from the vaccine strain.
Takeaway
This study looked at the flu viruses in Europe and found that while some matched the vaccine, others, especially A(H3N2), did not.
Methodology
Surveillance data were collected from EU/EEA countries through weekly submissions to The European Surveillance System (TESSy) for weeks 40/2023 to 9/2024.
Potential Biases
Potential bias in virus selection for characterisation and reporting inconsistencies across countries.
Limitations
Only a small percentage of detected viruses were characterised, and the selection processes for characterisation varied by country.
Participant Demographics
Data collected from 29 EU/EEA countries.
Statistical Information
Confidence Interval
95% CI: 41–63
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website